Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
Salt CompositionImipramine 25mg
You Searched
Impramine 25mg Tablet
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Depression / Bed-wetting
Customers also bought
More About Impramine
Benefits
In Depression Impramine 25mg Tablet is thought to work by affecting the balance of certain chemicals (such as serotonin) in the brain. It helps improve mood and feelings of wellbeing, relieve anxiety and tension, help you sleep better, and increase your energy level. It is used to treat depression that is unresponsive to other medicines. You need to take it regularly as it is prescribed for it to be most effective and should not stop taking it suddenly. In Bed-wetting Bed-wetting is a condition that is seen in children who are old enough to control their urine at night during sleep but fail to do so. Impramine 25mg Tablet can help your child control nighttime bed-wetting. Impramine 25mg Tablet works by blocking the effect of a certain natural substance (acetylcholine) on the bladder muscles. This prevents bladder overflow at night. However, this medicine is used for managing bed-wetting only during the night and should not be used in children younger than 6 years of age.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Impramine 25mg Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Impramine 25mg Tablet is a tricyclic antidepressant. It increases the levels of chemical messengers in the brain that help in regulating the mood and treat depression.
Unsafe: Avoid consuming alcohol with Impramine 25mg Tablet as it is deemed unsafe.
Seek medical advice from your doctor: Impramine 25mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Impramine 25mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Not Safe: Impramine 25mg Tablet may cause side effects which could affect your ability to drive. As Impramine 25mg Tablet may impair your alertness or cause drowsiness or blurred vision, and this may affect your ability to drive.
Caution Advised: Impramine 25mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Impramine 25mg Tablet may be needed. Doctor consultation is advised.
Caution Advised: Impramine 25mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Impramine 25mg Tablet may be needed. Doctor consultation is advised. Regular monitoring of liver function tests is recommended while you are taking this medicine.
What if I forget to take it?
If a dose of Impramine 25mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135
References
Stahl SM, editor. Imipramine. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 307-12
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 697
Drugs.com. Imipramine Pregnancy and Breastfeeding Warnings (25 Mar. 2019)
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. Jornal de Pediatria. 2004;80(5):4-6 (20 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (25 Mar. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
